Jean-Manasse Theagene
Direktor/Vorstandsmitglied bei MAIA BIOTECHNOLOGY, INC.
Vermögen: - $ am 31.05.2024
Profil
Jean-Manasse Theagene is the founder of 360Medlink, Inc. which was founded in 2010.
He held the title of President & Chief Executive Officer at the company.
He is currently working as an Independent Director at MAIA Biotechnology, Inc. since 2023.
In terms of education, he completed his undergraduate and graduate degrees at the University of Montréal and holds an MBA from HEC Montréal.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC.
-.--% | 31.03.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Jean-Manasse Theagene
Unternehmen | Position | Beginn |
---|---|---|
MAIA BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 17.03.2023 |
360Medlink, Inc.
360Medlink, Inc. Packaged SoftwareTechnology Services 360Medlink, Inc. operates as a software company which creates custom mobile and tablet innovations for healthcare and biotechnology organizations. The firm also offers software solutions to pharmaceutical marketing, medical affairs, and global clinical trials. The company is headquartered in Montreal, Canada. | Vorstandsvorsitzender | 01.11.2010 |
Ausbildung von Jean-Manasse Theagene
University of Montréal | Graduate Degree |
HEC Montréal | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MAIA BIOTECHNOLOGY, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
360Medlink, Inc.
360Medlink, Inc. Packaged SoftwareTechnology Services 360Medlink, Inc. operates as a software company which creates custom mobile and tablet innovations for healthcare and biotechnology organizations. The firm also offers software solutions to pharmaceutical marketing, medical affairs, and global clinical trials. The company is headquartered in Montreal, Canada. | Technology Services |